Pharos iBio Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-10,757	-10,560	-8,858	-17,062	-31,471
Depreciation & Amortization	837.49	802.91	684.91	578.1	350.09
Loss (Gain) From Sale of Assets	0.01	37.27	41.7	-24.43	-3.2
Stock-Based Compensation	597.02	484.25	533.61	618.15	386.27
Other Operating Activities	592.18	-273.67	15.56	7,683	24,007
Change in Other Net Operating Assets	382.69	182.08	169.48	22.76	-588.38
Operating Cash Flow	-8,347	-9,327	-7,413	-8,184	-7,319
Capital Expenditures	-15.22	-676.78	-839.64	-328.28	-1,170
Sale of Property, Plant & Equipment	-	-	4	46.32	14.55
Sale (Purchase) of Intangibles	-27.5	-341.44	-15.1	-5.8	-310.81
Investment in Securities	8,827	590.7	1,368	-6,267	-
Other Investing Activities	1.8	19.83	-43.18	-11.92	-91.25
Investing Cash Flow	8,787	-407.69	474.34	-6,567	-1,557
Long-Term Debt Issued	19,000	-	-	-	-
Long-Term Debt Repaid	-157.44	-163.6	-267.2	-271.11	-383.72
Net Debt Issued (Repaid)	18,843	-163.6	-267.2	-271.11	-383.72
Issuance of Common Stock	-	132.12	19,073	-	-
Other Financing Activities	-97.6	-	-0	-	-2
Financing Cash Flow	18,745	-31.48	18,805	-271.11	17,635
Foreign Exchange Rate Adjustments	-11.04	538.18	-90.8	21.67	246.65
Net Cash Flow	19,173	-9,228	11,776	-15,000	9,005
Free Cash Flow	-8,362	-10,004	-8,253	-8,512	-8,489
Free Cash Flow Margin	-	-	-	-2837.42%	-14892.94%
Free Cash Flow Per Share	-646.04	-773.98	-681.98	-958.46	-1462.70
Cash Interest Paid	-	-	6.69	16.94	17.68
Cash Income Tax Paid	-85.69	19.49	74.11	10.01	6.62
Levered Free Cash Flow	-5,883	-8,142	-6,202	-50,167	14,875
Unlevered Free Cash Flow	-5,844	-8,139	-6,195	-48,153	18,946
Change in Working Capital	382.69	182.08	169.48	22.76	-588.38

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.